Company Overview of Ruder Finn, Inc.

Snapshot

People

Overview Board Members Committees

Executive Profile

Kathy Bloomgarden Ph.D.

Co-Chief Executive Officer, Ruder Finn, Inc.

Age	Total Calculated Compensation	This person is connected to 1 Board Members in 1 different organizations across 2 different industries. See Board Relationships
--	--

Background

Dr. Kathy Bloomgarden PhD serves as a Co-Chief Executive Officer at Ruder Finn Inc. Dr. Bloomgarden has a working knowledge of Chinese, Italian, and basic German and Russian. Dr. Bloomgarden started the agency's Healthcare practice in 1980. Dr. Bloomgarden was instrumental in developing Ruder Finn's corporate affairs practice, was the team leader in one of the PR industry's largest campaigns, the merger and corporate positioning for Novartis, Ruder Finn formed from the ... merger of Sandoz and Ciba-Geigy. Dr. Bloomgarden headed the communications preparations during the merger negotiations, including counseling management, writing press materials, shareholder information, analysts' briefing materials, and preparing logistics of the announcement events. Dr. Bloomgarden spearheaded the BP Amoco merger, working with the integration office and directing efforts aimed at keeping people around the world informed of merger-related changes, including site selection, management appointments and restructuring activities. Based on more than 20 years of experience in communications for multinational companies, including global communications activities for Novartis, BP, Pfizer, AB Volvo, Microsoft, Credit Suisse, AXA-Midi, Lyonnaise des Eaux, Paribas and ABB, Dr. Bloomgarden has developed particular skills in global communications consulting, including a focus on the following areas: Leadership and Chief Executive Officer positioning: helping top management develop a strong communications platform and shape thinking on emerging trends internally and externally, Product launches and life cycle management: public relations support for coordinated, high-impact global launches that can rapidly achieve targets, and have a major impact on performance, Global corporate positioning and brand strategy: for multinational corporations, focused on generating recognition for key messages, core strategies and competencies, and evolving reputations around the world, Acquisition/merger and global integration programming: for companies going through a merger process followed by implementation of integration plans, programs which strive to build a new company culture which takes the best of both companies and forms a new company with a novel purpose and new way of doing business Change management: for companies going through restructuring/reengineering, to improve global competitiveness, activities which aim to motivate and engage the workforce, build commitment to new values and stretched targets, focus attention on improving performance, Values and corporate governance: for companies with operations in countries around the world, to reinforce a value set that guides business activities and is an ethical platform for management. She serves as a Director at The Partnership for New York City, Inc. Dr. Bloomgarden is a Member of The Council on Foreign Relations, the Foreign Policy Association and the Women's Forum, and serves on the communications committee for Brown University. Dr. Bloomgarden was awarded the PR industry's All-Star award for these efforts, as well as the industry's prestigious Silver Anvil prize. She graduated with a B.A. from Brown University, and has an M.A. and a Ph.D. from Columbia University in Political Science, as well as a certificate from the East Asian Institute. She is fluent in French.

Read Full Background